Measurement of Serum Anti-staphylococcal Antibodies Increases Positive Predictive Value of Preoperative Aspiration for Hip Prosthetic Joint Infection.


Journal

Clinical orthopaedics and related research
ISSN: 1528-1132
Titre abrégé: Clin Orthop Relat Res
Pays: United States
ID NLM: 0075674

Informations de publication

Date de publication:
12 2020
Historique:
pubmed: 16 7 2020
medline: 25 5 2021
entrez: 16 7 2020
Statut: ppublish

Résumé

Preoperative synovial fluid culture is pivotal in the early diagnosis of prosthetic joint infection (PJI) but may yield false-positive and false-negative results. We evaluated the predictive value of synovial fluid culture results combined with the measurement of serum anti-staphylococcal antibodies (SASA). (1) For hip and knee PJI, does combining positive SASA results with preoperative synovial culture results improve the positive predictive value (PPV) of preoperative synovial fluid culture alone? (2) Does combining preoperative synovial fluid culture results with a positive cell count and differential result increase the PPV of preoperative synovial fluid culture alone? (3) What proportion of isolated organisms exhibit concordance in antibiotic susceptibility: preoperative aspiration versus intraoperative isolates? A prospective study was conducted at two French reference centers that manage bone and joint infections and included 481 adult patients who had a revision or resection arthroplasty between June 25, 2012 and June 23, 2014. Exclusion criteria including no serum sample available for immunoassay, the lack of microbiological documentation, and the absence of preoperative aspiration reduced the patient number to 353. Seven patients with an undetermined SASA result were excluded from the analysis. We also excluded patients with PJI involving more than one Staphylococcus species (polystaphylococcal infection) and those in whom more than one Staphylococcus species was recovered from the preoperative synovial fluid culture (polystaphylococcal synovial fluid culture). In total, 340 patients were included in the analysis (no infection, 67% [226 of 340]; staphylococcal infection, 21% [71 of 340]; other infection, 13% [43 of 340]). The preoperative synovial fluid analysis included a cell count and differential and bacterial culture. SASAs were measured using a multiplex immunoassay. The diagnosis of PJI was determined using the Infectious Diseases Society of America (IDSA) criteria [] and intraoperative tissue culture at the time of revision surgery was used as the gold standard (at least one positive intraoperative sample for a "virulent" organism (such as S. aureus) or two positive samples for a "non-virulent" (for example S. epidermidis). SASA increased the PPV compared with synovial fluid culture alone (92% [95% CI 82 to 97] versus 79% [95% CI 68 to 87]; p = 0.04); when stratified by site, an increase in PPV was seen in hip infections (100% [95% CI 89 to 100] versus 77% [95% CI 63 to 88]; p = 0.01) but not in knee infections (84% [95% CI 66 to 95] versus 80% [95% CI 64 to 91]; p = 0.75). A positive cell count and differential result increased the PPV of staphylococcal synovial fluid cultures compared with synovial fluid culture alone (86% [95% CI 70 to 95] versus 79% [95% CI 68 to 87]; p = 0.36); when stratified by site, no difference in hip and knee infections was observed (86% [95% CI 67 to 96] versus 77% [95% CI 63 to 88]; p = 0.42) and 86% [95% CI 70 to 95] versus 80% [95% CI 64 to 91]; p = 0.74). SASA measurement improves the predictive value of synovial fluid cultures of the hip for all staphylococcal organisms, including coagulase-negative staphylococci, but the PPV of SASA plus synovial fluid culture it is not superior to the PPV of synovial fluid cell count/differential plus synovial culture for the knee. Level III, diagnostic study.

Sections du résumé

BACKGROUND
Preoperative synovial fluid culture is pivotal in the early diagnosis of prosthetic joint infection (PJI) but may yield false-positive and false-negative results. We evaluated the predictive value of synovial fluid culture results combined with the measurement of serum anti-staphylococcal antibodies (SASA).
QUESTIONS/PURPOSES
(1) For hip and knee PJI, does combining positive SASA results with preoperative synovial culture results improve the positive predictive value (PPV) of preoperative synovial fluid culture alone? (2) Does combining preoperative synovial fluid culture results with a positive cell count and differential result increase the PPV of preoperative synovial fluid culture alone? (3) What proportion of isolated organisms exhibit concordance in antibiotic susceptibility: preoperative aspiration versus intraoperative isolates?
METHODS
A prospective study was conducted at two French reference centers that manage bone and joint infections and included 481 adult patients who had a revision or resection arthroplasty between June 25, 2012 and June 23, 2014. Exclusion criteria including no serum sample available for immunoassay, the lack of microbiological documentation, and the absence of preoperative aspiration reduced the patient number to 353. Seven patients with an undetermined SASA result were excluded from the analysis. We also excluded patients with PJI involving more than one Staphylococcus species (polystaphylococcal infection) and those in whom more than one Staphylococcus species was recovered from the preoperative synovial fluid culture (polystaphylococcal synovial fluid culture). In total, 340 patients were included in the analysis (no infection, 67% [226 of 340]; staphylococcal infection, 21% [71 of 340]; other infection, 13% [43 of 340]). The preoperative synovial fluid analysis included a cell count and differential and bacterial culture. SASAs were measured using a multiplex immunoassay. The diagnosis of PJI was determined using the Infectious Diseases Society of America (IDSA) criteria [] and intraoperative tissue culture at the time of revision surgery was used as the gold standard (at least one positive intraoperative sample for a "virulent" organism (such as S. aureus) or two positive samples for a "non-virulent" (for example S. epidermidis).
RESULTS
SASA increased the PPV compared with synovial fluid culture alone (92% [95% CI 82 to 97] versus 79% [95% CI 68 to 87]; p = 0.04); when stratified by site, an increase in PPV was seen in hip infections (100% [95% CI 89 to 100] versus 77% [95% CI 63 to 88]; p = 0.01) but not in knee infections (84% [95% CI 66 to 95] versus 80% [95% CI 64 to 91]; p = 0.75). A positive cell count and differential result increased the PPV of staphylococcal synovial fluid cultures compared with synovial fluid culture alone (86% [95% CI 70 to 95] versus 79% [95% CI 68 to 87]; p = 0.36); when stratified by site, no difference in hip and knee infections was observed (86% [95% CI 67 to 96] versus 77% [95% CI 63 to 88]; p = 0.42) and 86% [95% CI 70 to 95] versus 80% [95% CI 64 to 91]; p = 0.74).
CONCLUSION
SASA measurement improves the predictive value of synovial fluid cultures of the hip for all staphylococcal organisms, including coagulase-negative staphylococci, but the PPV of SASA plus synovial fluid culture it is not superior to the PPV of synovial fluid cell count/differential plus synovial culture for the knee.
LEVEL OF EVIDENCE
Level III, diagnostic study.

Identifiants

pubmed: 32667753
doi: 10.1097/CORR.0000000000001392
pii: 00003086-202012000-00018
pmc: PMC7899396
doi:

Substances chimiques

Antibodies, Bacterial 0
Biomarkers 0

Types de publication

Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2786-2797

Commentaires et corrections

Type : CommentIn

Références

J Arthroplasty. 2018 May;33(5):1309-1314.e2
pubmed: 29551303
J Clin Microbiol. 2013 Nov;51(11):3830-4
pubmed: 23946521
J Bone Joint Surg Am. 2010 Sep 1;92(11):2102-9
pubmed: 20810860
Clin Microbiol Infect. 2019 Mar;25(3):353-358
pubmed: 29803842
J Bone Joint Surg Am. 2008 Sep;90(9):1869-75
pubmed: 18762646
J Bone Joint Surg Am. 2014 Sep 3;96(17):1439-45
pubmed: 25187582
Am J Med. 2004 Oct 15;117(8):556-62
pubmed: 15465503
J Bone Joint Surg Am. 2017 Dec 20;99(24):2077-2084
pubmed: 29257013
J Bone Joint Surg Am. 2009 Jul;91(7):1614-20
pubmed: 19571083
Joint Bone Spine. 2003 Dec;70(6):489-95
pubmed: 14667561
J Bone Joint Surg Br. 1989 Nov;71(5):851-5
pubmed: 2584258
J Clin Microbiol. 2010 May;48(5):1600-3
pubmed: 20181900
J Bone Joint Surg Am. 2008 Aug;90(8):1637-43
pubmed: 18676892
J Arthroplasty. 2006 Feb;21(2):221-6
pubmed: 16520210
Clin Orthop Relat Res. 2010 Jan;468(1):45-51
pubmed: 19554385
J Clin Microbiol. 2016 Apr;54(4):1065-73
pubmed: 26865683
Clin Microbiol Infect. 2011 Mar;17(3):447-50
pubmed: 20825439
Clin Microbiol Rev. 2014 Apr;27(2):302-45
pubmed: 24696437
J Arthroplasty. 1996 Aug;11(5):543-7
pubmed: 8872573
J Clin Microbiol. 2001 Dec;39(12):4468-71
pubmed: 11724863
Clin Infect Dis. 2013 Jan;56(1):e1-e25
pubmed: 23223583
J Bone Jt Infect. 2019 Sep 26;4(5):227-233
pubmed: 31700771
Infect Dis (Lond). 2018 Aug;50(8):609-615
pubmed: 29564939

Auteurs

Thomas Bauer (T)

T. Bauer, Service de Chirurgie Orthopédique et Traumatologie, Hôpital Ambroise Paré (Assistance Publique - Hôpitaux de Paris, AP-HP), Boulogne-Billancourt, France.

Simon Marmor (S)

S. Marmor, Centre de référence des infections ostéo-articulaires, Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France.

Idir Ghout (I)

I. Ghout, J. Ropers, Unité de Recherche Clinique Paris Île-de-France Ouest, Hôpital Ambroise Paré (AP-HP), Boulogne-Billancourt, France.

Elsa Salomon (E)

E. Salomon, F. El Sayed, J.-L. Gaillard, A.-L. Roux, Laboratoire de Microbiologie, Hôpital Ambroise Paré (AP-HP), Boulogne-Billancourt, France.
E. Salomon, F. El Sayed, M. Rottman, J.-L. Gaillard, A.-L. Roux, Université de Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France.

Faten El Sayed (F)

E. Salomon, F. El Sayed, J.-L. Gaillard, A.-L. Roux, Laboratoire de Microbiologie, Hôpital Ambroise Paré (AP-HP), Boulogne-Billancourt, France.
E. Salomon, F. El Sayed, M. Rottman, J.-L. Gaillard, A.-L. Roux, Université de Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France.

Beate Heym (B)

B. Heym, Service de Microbiologie, Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France.

Jacques Ropers (J)

I. Ghout, J. Ropers, Unité de Recherche Clinique Paris Île-de-France Ouest, Hôpital Ambroise Paré (AP-HP), Boulogne-Billancourt, France.

Martin Rottman (M)

M. Rottman, Laboratoire de Microbiologie, Hôpital Raymond Poincaré (AP-HP), Garches, France.

Jean-Louis Gaillard (JL)

E. Salomon, F. El Sayed, J.-L. Gaillard, A.-L. Roux, Laboratoire de Microbiologie, Hôpital Ambroise Paré (AP-HP), Boulogne-Billancourt, France.

Anne-Laure Roux (AL)

E. Salomon, F. El Sayed, M. Rottman, J.-L. Gaillard, A.-L. Roux, Université de Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH